SFX by Ex Libris Inc.

Title:	Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation
Source:	Science [0036-8075] Minajigi, A yr:2015

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	McHugh, Colleen A. "The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3." Nature 521.7551 (2015): 232-6.
description	2.	Blum, R. "Tailoring Ras-pathway—Inhibitor combinations for cancer therapy." Drug resistance updates 8.6 (2005): 369-380.
description	3.	Frame, M. "Src in cancer: deregulation and consequences for cell behaviour." Biochimica et biophysica acta. Reviews on cancer 1602.2 (2002): 114-130.
description	4.	Vousden, Karen H H. "Live or let die: the cell's response to p53." Nature reviews. Cancer 2.8 (2002): 594-604.
description	5.	Surka, Eric S. "RNA-RNA Interactions Enable Specific Targeting of Noncoding RNAs to Nascent Pre-mRNAs and Chromatin Sites." Cell 159.1 (2014): 188-99.
description	6.	Yang, F. "Reciprocal Regulation of HIF-1Î± and LincRNA-p21 Modulates the Warburg Effect." Molecular cell 53.1 (2013): 88-100.
description	7.	Furuya, F. "Ligand-bound Thyroid Hormone Receptor Contributes to Reprogramming of Pancreatic Acinar Cells into Insulin-producing Cells." Journal of biological chemistry 288.22 (2013): 16155-16166.
description	8.	Kinross, Kathryn M. "An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice." The Journal of clinical investigation 122.2 (2012): 553-557.
description	9.	Memili, E. "Murine Xist RNA isoforms are different at their 3 ' ends: a role for differential polyadenylation." Gene 266.1-2 (2001): 131-137.
description	10.	Downward, J. "Targeting RAS signalling pathways in cancer therapy." Nature reviews. Cancer 3.1 (2003): 11-22.
description	11.	Nahta, R. "Herceptin: mechanisms of action and resistance." Cancer Letters 232.2 (2006): 123-38.
description	12.	Vousden, Karen H H. "P53 and prognosis: new insights and further complexity." Cell 120.1 (2004): 7-10.
description	13.	Wu, X. "The p53-mdm-2 autoregulatory feedback loop." Genes & development 7.7A (1993): 1126-1132.
description	14.	Okada, H. "Pathways of apoptotic and non-apoptotic death in tumor cells." Nature reviews. Cancer 4.8 (2004): 592-603.
description	15.	Fodde, R. "APC, signal transduction and genetic instability in colorectal cancer." Nature reviews. Cancer 1.1 (2001): 55-67.
description	16.	Vousden, K. "Outcomes of p53 activation - spoilt for choice." Journal of cell science 119.24 (2006): 5015-5020.
description	17.	Shimada, H. "Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma." Cancer Science 97.6 (2006): 554-61.
description	18.	Mitra, Satyajit K K. "Integrin-regulated FAK-Src signaling in normal and cancer cells." Current opinion in cell biology 18.5 (2006): 516-23.
description	19.	Kelland, L. "The resurgence of platinum-based cancer chemotherapy." Nature reviews. Cancer 7.8 (2007): 573-584.
description	20.	Minajigi, A. "A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation." Science 349.6245 (2015): 1-.